[meteor_slideshow slideshow=”adssa” metadata=”height: 126, width: 630″]
Regulatory CMC team mender would document and submit changes in the manufacturing process during Phase 2 and 3 clinical trials.
What do you need to do if you need to introduce a new manufacturing facility after the approval?
NOTICE: It’s more of regulatory affairs and health policy than medicine and health.
[meteor_slideshow slideshow=”best” metadata=”height: 126, width: 630″]